The impact of age at onset of bipolar I disorder on functioning and clinical presentation by Biffin, F. et al.
ASPR Annual Meeting 2006
242
The COMT val158met genetic variant 
predicts antidepressant treatment 
response in major depression
B Baune1, V Arolt2
1School of Medicine, James Cook University, Townsville, Australia; and 
2Department of Psychiatry and Psychotherapy, University of Munster, 
Munster, Germany
Background: In this study, it was hypothesized that 
higher COMT activity as conferred by the COMT 
158val allele leading to decreased norepinephrine and 
dopamine availability has a negative effect on antide-
pressant drug response in depression.
Methods: A sample of 322 unrelated Caucasian pa-
tients with affective disorders (DSM-IV: major de-
pression, n = 256, bipolar disorder, n = 66) was 
characterized and genotyped for the COMT val158met 
variant. Weekly Hamilton Depression Rating Scale 
(HAM-D) scores during antidepressant treatment 
(SSRIs, NSRIs, NaSSA) were assessed. Statistical 
analysis was performed using stratifi ed and adjusted 
multivariate ANOVA (Bonferroni post hoc test).
Results: The COMT 158val/val genotype as compared 
with the 158val/met genotype conferred a signifi cant 
risk of worse response after 4–6 weeks of antidepres-
sant treatment in patients with affective disorders 
(week 4: P = 0.030; week 5: P = 0.002; week 6: 
P = 0.003). Even more signifi cant results were ob-
tained for the subsample restricted to major depression 
(week 4: P = 0.014; week 5: P = 0.000; week 6: 
P = 0.000). Statistical comparison of COMT 158val/
val vs. COMT 158met/met genotype with respect to 
therapy response showed a less pronounced negative 
effect of the COMT 158val/val genotype (week 5: 
P = 0.037; week 6: P = 0.096) in the sample of 
patients with major depression. In the subsample of 
patients with bipolar disorder, major depressive epi-
sode, no infl uence of the COMT val158met variant on 
HAM-D overall change scores could be detected. Fur-
ther stratifi ed results are presented.
Conclusions: In patients homozygous for the higher 
activity COMT 158val allele, the consecutive de-
creased availability of the monoamines norepinephrine 
and dopamine might impair the effi cacy of antide-
pressants during pharmacological treatment in major 
depression.
Childhood trauma and psychosis: a 
critical review
S Bendall
ORYGEN Research Centre and Department of Psychology, The University of 
Melbourne, Melbourne, Australia
Background: A signifi cant proportion of people with 
psychotic disorders report traumatic experiences in 
childhood, such as sexual and physical abuse. Simi-
larly, a proportion of childhood trauma (CT) survivors 
report psychotic symptoms such as hallucinations and 
delusions. Are these psychotic symptoms in trauma 
survivors part of the sequelae of CT or do they co-
 occur by chance? Much of the research into the rela-
tionship between CT and psychosis has suffered from 
a lack of methodological rigor and thus has failed to 
answer this question. Past reviews have paid little at-
tention to these methodological problems (Read 1997, 
2005; Morrison 2003). The aim of this review was to 
synthesize and critically evaluate the evidence.
Method: Medline and Psychinfo databases were sys-
tematically searched and papers identifi ed were assessed 
according to eligibility criteria. The reference sections 
of identifi ed papers were also searched.
Results: Forty-nine papers were identifi ed. The rates 
of CT reported in groups with psychosis ranged be-
tween 19% and 83%. Child sexual abuse prevalence 
rates ranged between 17% and 79%. Reports of child 
physical abuse ranged from 10% to 61%. When com-
pared with nonclinical controls, those with psychosis 
reported more trauma. Epidemiological studies inves-
tigating the relationship of CT to psychotic diagnosis 
and symptoms have found mixed results. However, all 
studies have methodological problems.
Conclusions: These studies tentatively suggest a re-
lationship between CT and psychosis. Further good 
quality research is needed to clarify any association.
The impact of age at onset of bipolar 
1 disorder on functioning and clinical 
presentation
F Biffi n1, S Tahtalian1, K Filia1, PB Fitzgerald1, 
AR De Castella1, S Filia1, M Berk2, S Dodd2, 
L Berk2, P Callaly2, J Kulkarni1
1Alfred Psychiatry Research Centre, Monash University; and 2Department of Clinical 
and Biomedical Sciences: Barwon Health, The University of Melbourne, 
Melbourne, Australia
Background: Recent studies have proposed the exis-
tence of three distinct subgroups of bipolar 1 based on 
age at onset (AAO) (Bellivier et al. 2003: Am J Psychi-
atry: 160: 999–1001; Patel et al. 2006: Bipolar Disor-
ders: 8: 91–94). The present study aims to investigate 
potential clinical and functional differences between 
these subgroups.
Method: Participants (n = 240) were enrolled in 
the Bipolar Comprehensive Outcomes Study, a 2-year 
longitudinal observational study. Measures assessed 
included the Young Mania Rating Scale, Hamilton 
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 Depression Rating Scale (HAMD21), Clinical Global 
Impressions Scale (CGI-BP), SF-36, SLICE/Life Scale 
and the EuroQol. Participants were also asked about 
age at fi rst major affective episode.
Results: Our data support the existence of three 
subgroups; early (AAO <20, mean = 15.47 ± 2.7) 
46.5% of participants, intermediate (AAO 20–35, 
mean = 25.52 ± 4.4) 43.8% of participants and 
late (AAO >35, mean = 46.2 ± 10.1) 9.7% of par-
ticipants. The groups differed signifi cantly in the type 
of fi rst episode experienced (χ2 = 14.88, df = 1, 
P = 0.005) such that the early subgroup were more 
likely to experience a depressive fi rst episode, while 
the intermediate subgroup were more likely to expe-
rience a manic fi rst episode. At enrollment, the early 
subgroup reported more severe depressive symptoms 
[HAM-D F(1, 153) = 10.20, P = 0.007]. When the 
early subgroup was compared with the typical sub-
group (intermediate and late combined), the early sub-
group tended to experience more clinically signifi cant 
distress as a result of depression (CGI-BP; χ2 = 3.73, 
df = 1, P = 0.053), were less satisfi ed with their over-
all health (SF-36; χ2 = 9.42, df = 4, P = 0.051) and 
were less able to enjoy recreational activities (SLICE; 
χ2 = 10.47,  df = 4,  P = 0.033).
Conclusions: Several clinical and functional differences 
were found between the subgroups based on preliminary 
data. These differences are important as they can help 
guide clinical management of this debilitating disorder.
Neuropsychological function in social 
phobia
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Background: Studies of neuropsychological function 
in social phobia have focused on attentional processes, 
memory function, judgment and interpretation biases, 
but fi ndings have been confl icting. Differences in clinical 
characteristics or variation in testing paradigms and tasks 
may account for the inconsistencies. This study aimed to 
assess several cognitive functions, including verbal de-
clarative memory, working memory, verbal fl uency and 
recognition memory for visuospatial information.
Methods: Thirty adults who met DSM-IV criteria for 
social phobia and 27 age- and gender-matched healthy 
controls aged between 18 and 65 years completed 
neuropsychological testing. Participants were recruited 
by means of newspaper advertisements. Severity of 
social phobia was rated using the Liebowitz Social 
Anxiety Scale. Participants completed a battery of 
neuropsychological tests including the Rey Auditory 
Verbal Learning Test, spatial span, spatial recogni-
tion memory, spatial working memory, digit span, and 
verbal fl uency and a verbal memory task comprising 
nonsense words. The National Adult Reading Test was 
used to estimate premorbid verbal IQ.
Results: There were no signifi cant group differences on 
any domain of function, including verbal learning and 
memory, attention, working memory, verbal  fl uency, 
visuospatial functioning or psychomotor speed.
Conclusions: Social phobia was not associated with neu-
ropsychological impairment, but clinical characteristics 
of the sample may account for this. Patients were high-
functioning individuals with mild to moderate social pho-
bia who had not specifi cally sought help for social phobia.
The multiscale hypothesis of bipolar 
disorder
M Breakspear
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The brain is characterized by the presence of architec-
tural structures – neurons, minicolumns, cortical col-
umns – across a hierarchy of spatial scales. In addition, 
the activity of the brain is expressed – through action 
potentials, EEG oscillations, diurnal rhythms – across 
a multitude of temporal scales. We propose that bipo-
lar disorder arises as a biological disturbance at a very 
fi ne spatial and temporal scale, within transmembrane 
dynamics, which then cascades across scales to be ex-
pressed at the slower scales of symptoms, episodes and 
ultimately the illness across the life span. This proposal 
is embedded within a hierarchical model of neocortical 
activity. Innovative data analysis methods, allowing 
the investigation of EEG and functional magnetic reso-
nance imaging data from such a multiscale perspective, 
are presented. We hence propose a set of functional 
neuroscience experiments that would allow this ‘mul-
tiscale hypothesis’ of bipolar disorder to be tested.
Referential delusions of communication 
and self-monitoring defi cits in 
psychosis
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Background: Although delusions of reference are 
one of the most frequently occurring symptoms of 
